Lidocaine Hydrochloride CAS# 73-78-9
Lidocaine hydrochloride is an anesthetic as well as an antiarrhythmic drug. Clinically, it is mainly used for infiltration anesthetic, epidural anesthetic, topical anesthesia (consisting of mucosal anesthetic throughout thoracoscopic examination or abdominal surgical treatment) as well as nerve conduction block. It can additionally be used for early ventricular tightenings and also ventricular tachycardia after acute myocardial infarction, and also for ventricular arrhythmias triggered by digitalis poisoning, cardiac surgery as well as cardiac catheterization. But it is usually inadequate for supraventricular arrhythmias.
Lidocaine Hydrochloride CAS# 73-78-9
| Lidocaine hydrochloride Basic information |
| General?Physical and chemical properties?Local anesthetic and antiarrhythmic drugs?Application?Metabolism?Indications?Usage and dosage?Adverse effect?Additional information?Medicine interactions?Precautions?References |
| Product Name: | Lidocaine hydrochloride |
| Synonyms: | Lidocaine hydrochloride CP2000,BP98;a-(diethylamino)-26-acetoxylidideHCl;a-(diethylamino)-26-acetoxylididehydrochloride;2-(Diethylamino)-N-(2,6-dimethylphenyl)-acetamide hydrochloride;6??-acetoxylidide,2-(diethylamino)-2hydrochloride;6??-acetoxylidide,2-(diethylamino)-2monohydrochloride;Acetamide,2-(diethylamino)-N-(2,6-diethylphenyl)-,monohydrochloride;Acetamide,2-(diethylamino)-N-(2,6-dimethylphenyl)-,monohydrochloride |
| CAS: | 73-78-9 |
| MF: | C14H23ClN2O |
| MW: | 270.8 |
| EINECS: | 200-803-8 |
| Product Categories: | Pharma materials;Pharmaceutical intermediates;Amines;Aromatics;Research Chemical;Intermediates & Fine Chemicals;Pharmaceuticals;API;Others;73-78-9 |
| Mol File: | 73-78-9.mol |
 |
|
| Lidocaine hydrochloride Chemical Properties |
| Melting point | 80-82??C |
| storage temp. | Inert atmosphere,2-8??C |
| form | Solid |
| color | White to off-white |
| Water Solubility | Water : ?? 36 mg/mL (132.94 mM) |
| InChI | InChI=1S/C14H22N2O.ClH/c1-5-16(6-2)10-13(17)15-14-11(3)8-7-9-12(14)4;/h7-9H,5-6,10H2,1-4H3,(H,15,17);1H |
| InChIKey | IYBQHJMYDGVZRY-UHFFFAOYSA-N |
| SMILES | C(NC1=C(C)C=CC=C1C)(=O)CN(CC)CC.[H]Cl |
| LogP | 2.359 (est) |
| CAS DataBase Reference | 73-78-9(CAS DataBase Reference) |
| EPA Substance Registry System | Acetamide, 2-(diethylamino)-N-(2,6-dimethylphenyl)-, monohydrochloride (73-78-9) |
Related Products
Chemical Name: Trelagliptin succinate
CAS No.: 1029877-94-8
Molecular Fomula: C22H26FN5O6
Molecular weight: 475.48
Appearance: White powder
Assay: ??99.0%
Chemical Name: Semaglutide
CAS No.: 910463-68-2
Molecular Formula: C187H291N45O59
Molecular Weight: 4113.57754
Appearance: Powder
Chemical Name: Tylosin tartrate
CAS No.:?74610-55-2
Appearance:?white powder
Assay????98.0%
Chemical Name: Abemaciclib
CAS No.: 1231929-97-7
Molecular Formula: C27H32F2N8
Molecular Weight: 506.59
Chemical Name: Potassium Castorate
CAS No.: 8013-05-6
Molecular Formula: C57H107K3O12
Molecular Weight: 1101.74718
Appearance: Yellow Liquid
Common English name: 5-iodo-2,3-dihydropyridazin-3-one
CAS No.: 825633-94-1
Molecular formula: C4H3IN2O
Molecular weight: 221.98
Sample: Available
Chemical Name: Dehydrocholic acid
Synonyms: Acide dehydrocholique; Triketocholanic acid
CAS No.: 81-23-2
Molecular Formula: C24H34O5
Molecular Weight: 402.53
Appearance: Powder
Chemical Name:?Favipiravir
CAS No.:?259793-96-9
Molecular Fomula:?C5H4FN3O2
Molecular weight:?157.1
Appearance:?Off white solid
Assay: 99 % min
Chemical Name: Zinc citrate
Synonyms: Zinc citrate trihydrate
CAS No.: 546-46-3
Molecular Formula: C6H8O7Zn
Molecular Weight: 257.5
Appearance: White powder
Chemical Name: Imazalil Sulfate
CAS No.: 58594-72-2
Molecular Formula: C14H14Cl2N2O.H2SO4
Molecular Weight: 395.26
Appearance: Solid
Levodopa, also known as L-DOPA or 3,4-dihydroxy-L-phenylalanine, is a naturally occurring amino acid and a critical precursor in the biosynthesis of the neurotransmitters dopamine, norepinephrine, and epinephrine. With the molecular formula C9H11NO4, levodopa is a large, neutral amino acid that plays a significant role in the treatment of Parkinson’s disease due to its ability to cross the blood-brain barrier and be converted into dopamine.
Chemically, levodopa is synthesized from the precursor amino acid tyrosine through the action of the enzyme tyrosine hydroxylase. As a medication, levodopa is often formulated with a peripheral DOPA decarboxylase inhibitor to reduce its conversion to dopamine outside the brain, thereby increasing its effectiveness and reducing side effects.
Levodopa is characterized by its effectiveness in alleviating the motor symptoms of Parkinson’s disease, such as tremors, rigidity, and bradykinesia. It is typically administered orally and absorbed from the gastrointestinal tract, where it is then transported to the brain.
In summary, levodopa is a vital pharmaceutical compound used in neurology for its role in treating Parkinson’s disease by replenishing the brain’s dopamine levels. Its targeted delivery and conversion to dopamine make it an essential treatment option for managing the motor symptoms associated with this condition.
Chemical Name: Marbofloxacin
CAS No.: 115550-35-1
Molecular Formula: C17H19FN4O4
Molecular Weight: 362.36
Appearance: Red-Brown Crystal
